Study Supports Use of CRi's Imaging Technology to Measure Biomarkers in Intact Tissue, Firm Says | GenomeWeb

This story originally ran on Dec. 1.

Cambridge Research & Instrumentation announced the results today of a study it said demonstrates for the first time the ability to "detect and automatically measure key activity indicators of cancer cell signal transduction pathways in intact tissue."

According to the Woburn, Mass.-based firm, the study suggests CRi's imaging and analysis platform may have use in clinical studies for the assessment of protein biomarkers for patient selection, drug response, and molecular diagnostic development.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.